SS Innovations International (NASDAQ: SSII) will feature its SSi Mantra surgical robotic system at the 2026 Society of Robotic Surgery Annual Meeting, scheduled for July 23-26 in Hollywood, Florida. The system will be displayed throughout the event, demonstrated in multiple breakout sessions, and used in a live broadcast of a remote partial nephrectomy performed by Dr. Amitabh Singh from the company’s headquarters in Gurugram, India, on a patient at Rajeev Gandhi Cancer Institute and Research Centre in New Delhi.
Chairman and CEO Dr. Sudhir Srivastava will participate as a speaker and panelist in sessions covering telesurgery, robotic surgery adoption, regulatory frameworks, and global access to robotic care. As of July 6, 2026, the SSi Mantra system had been used in 12,375 procedures spanning more than 170 procedure types, including 653 cardiac procedures, 178 telesurgeries, and 225 pediatric surgeries. Approximately 2,100 physicians have been trained on the platform.
The demonstration underscores the growing role of telesurgery in expanding access to specialized surgical care. The live remote procedure, connecting Gurugram to New Delhi, highlights the potential for surgeons to operate on patients in distant locations, a capability that could reduce disparities in healthcare access. The SSi Mantra system’s versatility across diverse procedure types, from cardiac to pediatric surgeries, suggests its broad applicability in various medical fields.
The annual meeting provides a platform for SS Innovations to showcase its technology to a global audience of surgeons, researchers, and industry leaders. Dr. Srivastava’s participation in discussions on regulatory frameworks and global access indicates the company’s focus on navigating the complex approval processes needed to bring robotic surgery to more countries. The company’s vision, as stated in the press release, is to make robotic surgery affordable and accessible to a larger segment of the global population.
The SSi Mantra system, along with the SSi Mudra surgical instruments, supports a variety of procedures including cardiac surgery. The company, an American entity headquartered in India, plans to expand its global presence. The press release notes that as of early July, the system had been used in over 12,000 procedures, reflecting significant adoption since its launch.
The event also highlights the importance of training, with 2,100 physicians already trained on the platform. This training infrastructure is critical for widespread adoption, as surgeons must be proficient in using the technology to ensure patient safety and optimal outcomes. The company’s focus on telesurgery could further accelerate training by allowing remote proctoring and collaboration.
Investors and industry observers will be watching for any announcements regarding regulatory approvals or partnerships during the meeting. The forward-looking statements in the press release caution that actual results may differ materially from expectations due to various risks and uncertainties, as detailed in the company’s SEC filings. For more information, the full press release is available at https://ibn.fm/YYYKE.
